TMCnet News
DiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference CallMINNEAPOLIS, March 18, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its 2018 financial results will be released after market close on Tuesday, March 19th. DiaMedica’s management will host a live conference call on Wednesday, March 20th at 8:00am Central Time to provide a business update and discuss the Company’s financial results. Conference Call details:
About DiaMedica Therapeutics Inc. DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney diseases and neurological disorders. The Company currently has an ongoing phase II study in acute ischemic stroke and a phase Ib study in chronic kidney disease. DiaMedica’s shares are listed on The Nasdaq Capital Market under the trading symbol “DMAC.” For more information, please visit www.diamedica.com. Contact: Scott Kellen Paul Papi |